全文获取类型
收费全文 | 2036篇 |
免费 | 171篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 82篇 |
妇产科学 | 15篇 |
基础医学 | 346篇 |
口腔科学 | 15篇 |
临床医学 | 249篇 |
内科学 | 643篇 |
皮肤病学 | 10篇 |
神经病学 | 102篇 |
特种医学 | 171篇 |
外科学 | 146篇 |
综合类 | 41篇 |
一般理论 | 2篇 |
预防医学 | 146篇 |
眼科学 | 32篇 |
药学 | 129篇 |
中国医学 | 2篇 |
肿瘤学 | 83篇 |
出版年
2022年 | 13篇 |
2021年 | 31篇 |
2019年 | 14篇 |
2018年 | 18篇 |
2017年 | 13篇 |
2016年 | 30篇 |
2015年 | 31篇 |
2014年 | 47篇 |
2013年 | 78篇 |
2012年 | 70篇 |
2011年 | 78篇 |
2010年 | 46篇 |
2009年 | 47篇 |
2008年 | 66篇 |
2007年 | 81篇 |
2006年 | 75篇 |
2005年 | 87篇 |
2004年 | 84篇 |
2003年 | 66篇 |
2002年 | 68篇 |
2001年 | 56篇 |
2000年 | 58篇 |
1999年 | 55篇 |
1998年 | 65篇 |
1997年 | 85篇 |
1996年 | 53篇 |
1995年 | 47篇 |
1994年 | 54篇 |
1993年 | 37篇 |
1992年 | 61篇 |
1991年 | 52篇 |
1990年 | 36篇 |
1989年 | 50篇 |
1988年 | 57篇 |
1987年 | 37篇 |
1986年 | 38篇 |
1985年 | 42篇 |
1984年 | 27篇 |
1983年 | 15篇 |
1982年 | 17篇 |
1981年 | 14篇 |
1980年 | 16篇 |
1979年 | 14篇 |
1978年 | 23篇 |
1977年 | 19篇 |
1976年 | 19篇 |
1975年 | 19篇 |
1974年 | 14篇 |
1971年 | 13篇 |
1969年 | 12篇 |
排序方式: 共有2218条查询结果,搜索用时 46 毫秒
11.
Factors influencing women to undergo screening mammography 总被引:2,自引:0,他引:2
12.
Audit of opioid prescribing: the effect of hospital guidelines 总被引:1,自引:0,他引:1
13.
A 39 year old man with Marfan syndrome presented with multiple pulmonary emboli and renal, hepatic, and splenic infarcts of unknown aetiology. The combination of thromboemboli and physical features initially suggested homocystinuria; however, laboratory examination showed no evidence for this disorder. Laboratory evaluation identified no coagulation abnormalities. This patient represents the unusual occurrence of hypercoagulability in a patient with Marfan syndrome. 相似文献
14.
Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. 下载免费PDF全文
R. G. Humphries W. Tomlinson J. A. Clegg A. H. Ingall N. D. Kindon P. Leff 《British journal of pharmacology》1995,115(6):1110-1116
1. We measured the ratio of ETA and ETB sub-types in the media (containing mainly smooth muscle) of human cardiac arteries (aorta, pulmonary and coronary), internal mammary arteries and saphenous veins. 2. In saturation experiments, [125I]-endothelin-1 ([125I]-ET-1) bound with high affinity to the media of each vessel (n = 3 individuals or homogenate preparations +/- s.e. mean): coronary artery, KD = 0.14 +/- 0.02 nM, Bmax = 71.0 +/- 21.0 fmol mg-1 protein; pulmonary artery, KD = 0.85 +/- 0.25 nM, Bmax = 15.2 +/- 10.3 fmol mg-1 protein; aorta, KD = 0.51 +/- 0.02 nM, Bmax = 9.4 +/- 4.4 fmol mg-1 protein; internal mammary artery. KD = 0.34 +/- 0.31 nM, Bmax = 2.0 +/- 0.5 fmol mg-1 protein and saphenous vein, KD = 0.28 +/- 0.05 nM, Bmax = 52.8 +/- 1.0 fmol mg-1 protein. In each vessel, over the concentration-range tested, Hill slopes were close to unity and a one site fit was preferred to a two site model. 3. In competition binding assays, the ETA selective ligand, BQ123 inhibited the binding of 0.1 nM [125I]-ET-1 to the media in a biphasic manner. In each case, a two site fit was preferred to a one or three site model: coronary artery, KDETA = 0.85 +/- 0.03 nM, KDETB = 7.58 +/- 2.27 microM, ratio = 89:11%; pulmonary artery, KDETA = 0.27 +/- 0.05 nM, KDETB = 24.60 +/- 5.34 microM, ratio = 92:8%; aorta, KDETA = 0.80 +/- 0.40 nM, KDETB = 2.67 +/- 2.60 microM ratio = 89:11%; saphenous vein, KDETA = 0.55 +/- 0.17 nM, KDETB = 14.4 +/- 0.26 microM, 85:15% (n = 3 individuals or homogenate preparations +/- s.e. mean). BQ123 showed up to 18000 fold selectivity for the ETA over the ETB sub-type. The ETA-selective ligand, [125I]-PD151242 labelled 85% of the receptors detected by a fixed concentration of [125I]-ET-1 in media of internal mammary artery, measured by quantitative autoradiography. In contrast, the density of ETB receptors detected with [125I]-BQ3020 was 7.0 +/- 1.5 amol mm-2, representing about 8% of [125I]-ET-1.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
15.
16.
17.
David Gable Saskia C Sanderson Steve E Humphries 《Clinical chemistry and laboratory medicine》2007,45(3):301-308
The current worldwide prevalence of type 2 diabetes (T2D) was estimated to be 2.8% in 2000, but it is predicted to increase to epidemic proportions in the coming decades, primarily due to lifestyle changes, particularly obesity. In the United Kingdom there are over 1.4 million men and women with T2D. In addition to a strong environmental element, the existence of an underlying genetic component to T2D risk is supported by twin studies, family studies and the widely different T2D prevalence across ethnic groups. Here we review data showing that several common genetic risk variants for T2D have now been successfully identified, with modest, but meta-analytical robust effects on risk (in the region of 1.1-1.5-fold risk per allele). Use of these in combination may have clinical utility in identifying subjects at high risk. Whether this information will be motivating to make the type of lifestyle changes that have been shown to reduce the rate of progression from the pre-diabetes state to overt T2D is discussed. 相似文献
18.
James L Onambele G Woledge R Skelton D Woods D Eleftheriou K Hawe E Humphries SE Haddad F Montgomery H 《European journal of applied physiology》2004,92(1-2):227-230
A reduction in interleukin-6 (IL-6) activity may contribute to the beneficial effects of hormone replacement therapy (HRT) on the menopausal decline in bone mineral density (BMD). We have examined this hypothesis using a genetic strategy. The –174C (rather than G) IL-6 gene variant is associated with lower IL-6 expression. As such, we might anticipate the C allele to be associated with a greater response to HRT. We have tested this hypothesis. Mean three-site [spine (L1-L4), neck of femur, and Wards triangle] BMD was measured in 65 women in a 1-year randomised controlled trial of HRT with 0.625 mg oestrogen/day and 0.15 mg norgestrel (n=30). Baseline BMD was genotype-independent for both the control and HRT group. In the control group, the percentage change in BMD after 1 year was similar between genotypes (P=0.45). In contrast, in the HRT group, the rise was genotype-dependent. Those homozygous for the G allele showed a 3.62 (2.14)% increase in BMD compared with 10.44 (4.68)% for the C-homozygous group. Heterozygotes had an intermediate BMD increase of 5.6 (2.82)% [P=0.006 (P value for interaction between HRT and genotype was 0.04)] Although the study was limited by its small sample size, these are the first data to demonstrate the importance of IL-6 genotype in determining response to oestrogen therapy, rather than its physiological withdrawal. 相似文献
19.
John S Thompson Claire Pomeroy Richard J Kryscio Stephen A Brown Donna Reece Rita Kramer Dianna S Howard Gary VanZant Suzanne Humphries Gordon Phillips 《Biology of blood and marrow transplantation》2004,10(12):858-866
To reduce the toxicity of traditional conditioning regimens for allogeneic stem cell transplantation (allo-SCT), we used single-agent chemotherapy conditioning with either busulfan (total cumulative dose, 16 mg/kg) or melphalan (200 to 240 mg/m 2 ), followed by the anti-T cell-specific monoclonal antibody T10B9 (MEDI-500) daily for 3 days. T cell-replete SCT was performed from HLA-identical sibling donors. Acute graft-versus-host disease (aGVHD) prophylaxis consisted of 7 additional days of T10B9 and delayed onset of cyclosporine (ie, on day +4 or +5). Twenty-six high-risk hematologic malignancy patients were entered onto this study. All 24 patients who survived longer than 8 days engrafted, although 1 patient experienced late graft failure. Deaths occurred in 21 of 26 patients because of infection (n = 7), progression/recurrence of primary disease (n = 6), aGVHD (n = 4), regimen-related toxicity (n = 1), and other causes (n = 3). Five of these patients are enjoying disease-free survival with a median survival of 1193 days after allo-SCT. The conditioning regimen induced modulation of surface expression of CD3 (but not CD4 or CD8) and was associated with decreasing tumor necrosis factor-alpha (but not interleukin-6) serum levels. In conclusion, single-agent chemotherapy conditioning with T10B9 produced durable engraftment and long-term survival in some patients who would not have qualified for a traditional allo-SCT. 相似文献
20.